Sabril Patient Registry

Trial Profile

Sabril Patient Registry

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Aug 2016

At a glance

  • Drugs Vigabatrin (Primary)
  • Indications Complex partial epilepsy; Infantile spasms
  • Focus Adverse reactions
  • Sponsors Lundbeck A/S
  • Most Recent Events

    • 28 Jul 2016 Status changed from recruiting to completed.
    • 03 May 2014 Interim 4-year results presented at the 66th Annual Meeting of the American Academy of Neurology.
    • 03 Dec 2012 Three-year vision data from were presented as a late-breaking poster at the Annual Meeting of the American Epilepsy Society (AES) in December 2012.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top